This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Imperial Innovations Limited. Active years: 2015-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2016
Title: The Innovative Contributions of Catherine Jane Tralau-Stewart
Introduction
Catherine Jane Tralau-Stewart is a prominent inventor based in London, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating various diseases. With a total of 2 patents, her work is recognized for its potential impact on cancer and inflammatory diseases.
Latest Patents
Catherine's latest patents focus on Gadd45beta targeting agents. These patents include compounds based around tetrapeptide, tripeptide, and dipeptide moieties, along with corresponding peptoid moieties. The related methods and pharmaceutical compositions are designed for use in the treatment of cancer, inflammatory diseases, and other disorders.
Career Highlights
Catherine is associated with Imperial Innovations Limited, where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and a focus on addressing critical health challenges.
Collaborations
Catherine has collaborated with notable colleagues, including Guido Franzoso and Albert Andrzej Jaxa-Chamiec. These partnerships have further enhanced her research capabilities and broadened the scope of her inventions.
Conclusion
Catherine Jane Tralau-Stewart's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking in addressing complex health issues. Her patents and collaborations reflect a dedication to improving treatment options for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile